Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients

International Journal of Hematology ◽

10.1007/s12185-020-02863-4 ◽

2020 ◽

Vol 111 (6) ◽

pp. 877-887 ◽

Author(s):

Jung Yoon Choi ◽

Hyoung Jin Kang ◽

Hong Yul An ◽

Kyung Taek Hong ◽

Hee Young Shin

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Pediatric Lymphoma

Download Full-text

Cancer Research Highlights: High-Dose Chemo Plus Autologous Stem Cell Transplantation Boosts Event-Free Survival in Some Patients with Aggressive NHL

PsycEXTRA Dataset ◽

10.1037/e364142004-008 ◽

2004 ◽

Author(s):

Keyword(s):

Cancer Research ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Event Free Survival ◽

Download Full-text

Decision letter for "Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels"

10.1002/hon.2774/v2/decision1 ◽

2020 ◽

Keyword(s):

Vitamin D ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Download Full-text

Review for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/review1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/decision1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era"

10.1002/hon.2713/v1/decision1 ◽

2019 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Follicular Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Clinical Characteristics

Download Full-text

Faculty Opinions recommendation of Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108297.564322 ◽

2008 ◽

Author(s):

Xavier Leleu

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Plasma Cell ◽

Plasma Cell Disorders

Download Full-text

Faculty Opinions recommendation of A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995302.793474247 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase 1 ◽

Download Full-text

Faculty Opinions recommendation of Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725403083.793507191 ◽

2015 ◽

Author(s):

Greg Bociek

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Brentuximab Vedotin ◽

Consolidation Therapy ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Risk Of Relapse

Download Full-text

Faculty Opinions recommendation of Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727170548.793548360 ◽

2018 ◽

Author(s):

Leo Gordon

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Mantle Cell Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Cell Lymphoma ◽

Molecular Monitoring ◽

Download Full-text

Ofuji disease arising after autologous stem cell transplantation successfully treated with topical indomethacin

10.35531/ofuji ◽

2019 ◽

Author(s):

Amy H Huang

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation

Download Full-text